MedPath

Study on evaluation of treatment and prognosis using Bon Scan Index (BSI) in the bone scintigraphy at the prostate cancer bone metastases evaluatio

Not Applicable
Conditions
Prostate cancer with bone metastasis
Registration Number
JPRN-UMIN000007858
Lead Sponsor
Kanazawa University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
247
Inclusion Criteria

Not provided

Exclusion Criteria

prostate cancer without bone metastasis

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The correlation between rate of change PSA and the bone turnover markers and rate of change of the BSI by the treatment
Secondary Outcome Measures
NameTimeMethod
The correlation between progression-free survival and overall survival and rate of change of the BSI by the treatment
© Copyright 2025. All Rights Reserved by MedPath